INVIOS
LIVE

Serial Number

79355607

Owner

invIOs GmbH

Attorney

Michael J. Leonard

Filing Date

Jun 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

INVIOS Trademark

Serial Number: 79355607 • Registration: 8026380

INVIOS is a trademark filed by invIOs GmbH on June 21, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

invIOs GmbH (3 trademarks)

Campus-Vienna-Biocenter 5

Entity Type: 16

Trademark Details

Filing Date

June 21, 2022

Registration Date

November 18, 2025

Published for Opposition

January 9, 2024

Goods & Services

Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned

Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapy

Chemical, biochemical and biotechnological preparations used in industry and science

Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 19, 2024 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 7, 2024 OPNX
POST PUBLICATION AMENDMENT - ENTERED
Apr 22, 2024 CHPB
ASSIGNED TO PETITION STAFF
Apr 22, 2024 APET
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 17, 2024 OPNR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 13, 2024 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 5, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 8, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2023 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 4, 2023 NREP
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 5, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 5, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 6, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 17, 2022 REPR